The anti-viral molecule, called TBK-1, was found to be essential for cancer cells to live, so blocking it might point to a treatment for fighting cancer, the researchers report in today's issue of Cell.
"We got the surprise that this mechanism is involved in cancer cell survival, even though it's normally involved in immune response," said Dr. Michael White, associate professor of cell biology. "We found something a little bit different — an Achilles' heel of cancer cells that's apparently broadly conserved among many types of solid tumors."
Using cultured human cells, the researchers set out to study enzymes known to be involved in keeping cancer cells alive and proliferating. They soon narrowed the focus to one called RalB. This molecule is part of the Ras family of enzymes, which are mutated in 30 percent of all cancers and in 90 percent of pancreatic cancers.
The UT Southwestern scientists knew that RalB interacts with a protein complex called the exocyst, which helps small secretory packets in cells fuse to the cell membrane. The team isolated this complex, then chemically analyzed the proteins attached to it.
One protein they found on the exocyst, TBK-1, is known to be involved in cells' anti-viral response.
"There was nothing known about that mechanism to suggest how TBK-1 could drive cancer cell survival," Dr. White said.
The researchers found that TBK-1 is turned off in healthy cells unless the immune response is stimulated but was always active in the cancerous cells they studied. When they blocked the function of TBK-1 in both the cancerous and healthy cells, cancer cells died while healthy cells survived.
A German research team has studied clinical samples of tumors and found elevated levels of TBK-1, Dr. White said.
The TBK-1 action is part of an immune reaction called the "host defense response," which is distinct from the "adaptive" immune process, in which the body creates new antibodies against invading pathogens. A great deal is currently understood about how the adaptive immune system fights cancer and also helps create tissue environments permissive to cancer, Dr. White said, but a cancer-promoting role for the host defense response has not been previously seen.
It's a straightforward matter to block the action of TBK-1, so this might be a promising avenue for new cancer treatments, Dr. White said. Because that would also interfere with the body's immune function, however, a balance would have to be found between killing cancer cells and compromising a patient's ability to fight disease.
UT Southwestern researchers are now looking for chemicals that block TBK-1. They are also screening cancer cells for similar biochemical pathways essential to their survival but not essential in normal cells.
"This is making us think that there are many other surprises awaiting discovery regarding biological systems that are inappropriately subverted during development of cancer," Dr. White said.
Other UT Southwestern researchers involved in the study were Dr. Yu-chen Chien, postdoctoral researcher in cell biology; Dr. Sungchan Kim, senior research associate in biochemistry; Ron Bumeister, research scientist in physiology; Dr. Yueh-Ming Loo, postdoctoral researcher in microbiology; Dr. Sung Won Kwon, a former postdoctoral researcher in biochemistry now at Seoul National University; Cynthia Johnson, a microbiology student in the Medical Scientist Training Program; Dr. Michael Gale, associate professor of microbiology; and Dr. Yingming Zhao, associate professor of biochemistry. Researchers from the Institut Curie in France and the University of Iowa also participated.
The work was supported by the National Institutes of Health, the Robert E. Welch Foundation, the Susan G. Komen Breast Cancer Foundation and the Department of Defense Breast Cancer Research Program.
Aline McKenzie | EurekAlert!
Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute
Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.
Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
02.12.2016 | Medical Engineering
02.12.2016 | Agricultural and Forestry Science
02.12.2016 | Physics and Astronomy